Aeglea BioTherapeutics Inc.
Exchange: IEX Type: Common Stock
Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Aeglea BioTherapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Aeglea BioTherapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
Things Are About to Get Interesting For Healthcare Leveraged ETF via ETF TrendsPrestige Consumer Healthcare price target cut to $31 from $38 at D.A. Davidson via MarketWatch
The Week That Was In San Francisco: 2019 Should Be A Great Year For Healthcare Stocks via Seeking Alpha
Aeglea BioTherapeutics Inc. Performance
Active Alerts for IEX:AGLE
You don't have any alerts set for IEX:AGLE.
About Aeglea BioTherapeutics Inc.
Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.
Real-time AGLE to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.